MedPath

Improving Insomnia in Patients With Opioid Use Disorder

Not Applicable
Withdrawn
Conditions
Insomnia
Opioid Use Disorder
Interventions
Behavioral: Sleep Hygiene
Behavioral: Mindfulness
Registration Number
NCT05588726
Lead Sponsor
University of Pennsylvania
Brief Summary

This randomized, 35-day research study (n=20) explores the effects of a simplified mindfulness intervention in opioid use disorder patients stabilized on buprenorphine maintenance therapy (BMT), aiming to alleviate insomnia, monitor BMT dose, and decrease non-prescribed opioid use. Patients tap along with their breathing at bedtime and practice sleep hygiene; controls do sleep hygiene only. Adherence will be monitored by a smartphone application.

Detailed Description

This research study is exploring the effects of a simplified mindfulness intervention in patients with opioid use disorder who are stabilized on buprenorphine maintenance therapy. This study aims to improve their sleep quality, monitor changes in buprenorphine dose, and decrease the frequency of non-prescribed opioids use. We will be enrolling a total of 20 patients who are above 18 years of age and have insomnia symptoms, opioid use disorder, and access to a smartphone. Patients will be asked to utilize a smartphone application which will allow us to monitor adherence; they will be asked to tap on the screen in time with their breathing before bedtime. Buprenorphine maintenance therapy is used to treat opioid use disorder (the buprenorphine will be prescribed by their healthcare provider as part of their standard clinical care and is not a research study intervention) by minimizing withdrawal symptoms, but symptoms of insomnia often persist. Symptoms of insomnia include difficulty falling/staying asleep, anxiety regarding sleep, or daytime sleepiness.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Age greater than 18
  2. Diagnosed with Opioid Use Disorder
  3. Stable on Buprenorphine Maintenance Therapy for at least 4 weeks
  4. At least 3 nights of greater than 30 minutes of sleep onset latency
  5. Speak English above 6th grade level
  6. Access to smart device
Exclusion Criteria
  1. Inability to communicate verbally
  2. Involved in another insomnia study
  3. Medical or other factors that in the opinion of the study research team would interfere with their ability to participate in the intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MindfulnessSleep Hygiene-
MindfulnessMindfulness-
Sleep HygieneSleep Hygiene-
Primary Outcome Measures
NameTimeMethod
Sleep Onset LatencyDay 28

Time to fall asleep as derived from the Sleep Diary

Secondary Outcome Measures
NameTimeMethod
Daytime CravingsDays 1 through 14

Smartphone app usage during the day

Non-Prescribed Opioid UseDays -1, 7, 14, and 28

Non-Prescribed Opioid Use Questionnaire

Trial Locations

Locations (1)

Perelman School of Medicine, University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath